Skip to main content

Cancer Immunotherapy: Making Checkpoint Inhibition Even More Effective

Lawrence Fong, MD, Leader, Cancer Immunotherapy Program, Efim Guzik Distinguished Professor in Cancer Biology, Helen Diller Family Comprehensive Cancer Center, University of California, San Fancisco UNC Lineberger Cancer Center Oncology Grand Rounds Presentation hosted by Dr. William Kim

Breast Cancer Mutations as Diagnostic and Therapeutic Targets for Therapy

00-002 Joseph S. Pagano Conference Room, UNC Lineberger Comprehensive Cancer Center 450 West Drive, Chapel Hill, NC, United States

Ben Ho Park, MD, PhD, the Donna S. Hall Professor of Medicine, Vanderbilt University Medical Center, Co-Leader Breast Cancer Research Program, Associate Director for Translational Research, Director of Precision Oncology, Vanderbilt-Ingram Cancer Center